COMMON TREATMENTS WITH SEMAGLUTIDE MEET OUR WELLNESS DOCTORS Dr
In the 72-week STEP UP trial , participants who completed the full trial on Wegovy HD (7.2 mg) lost an average of 20.7% of their body weight
metformin SGLT2 inhibitors : These prescription drugs help lower blood sugar by causing the kidneys to remove sugar through the urine, effectively reducing overall glucose levels in the body
Semaglutide is an appetite suppressant that is primarily used to treat type 2 diabetes and obesity, as indicated, and approved by the Food and Drug Administration (FDA)
This detailed information allows your healthcare provider to identify potential contraindications, evaluate cumulative side effects, and make informed decisions about your treatment plan, ensuring your safety and optimizing outcomes
Do not use a pen you suspect has overheated